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Background: This study aimed to validate the effectiveness of the Osteoporosis Self-assessment Tool for Asians
(OSTA) in identifying postmenopausal women at increased risk of primary osteoporosis and painful new
osteoporotic vertebral fractures in a large selected Han Chinese population in Beijing.
Methods: We assessed the performance of the OSTA in 1201 women. Subjects with an OSTA index > -1 were
classified as the low risk group, and those with an index ≤ -1 were classified as the increased risk group.
Osteoporosis is defined by a T-score ≤ 2.5 standard deviations according to the WHO criteria. All painful, new
vertebral fractures were identified by X-ray and MRI scans with correlating clinical signs and symptoms. We
determined the sensitivity, specificity, and area under the receiver operating characteristic (ROC) curve for correctly
selecting women with osteoporosis and painful new vertebral fractures.
Results: Of the study subjects, 29.3% had osteoporosis, and the prevalence of osteoporosis increased progressively
with age. The areas under the ROC curves of the OSTA index (cutoff = -1) to identify osteoporosis in the femoral
neck, total hip, and lumbar spine were 0.824, 0.824, and 0.776, respectively. The sensitivity and specificity of the
OSTA index (cutoff = -1) to identify osteoporosis in healthy women were 66% and 76%, respectively. With regard to
painful new vertebral fractures, the area under the ROC curve relating the OSTA index (cutoff = -1) to new vertebral
fractures was 0.812.
Conclusions: The OSTA may be a simple and effective tool for identifying the risk of osteoporosis and new painful
osteoporotic vertebral fractures in Han Chinese women.
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With the progressive aging of populations, osteoporosis
has rapidly become a growing global health concern be-
cause of its age-associated, exponentially increasing preva-
lence, morbidity, mortality, and costs [1]. Osteoporosis,
which ultimately leads to fragility fractures, represents a
major public health problem in Asian countries, especially
China, which is the largest and most populous developing
country in the world. It is projected that 50% of the* Correspondence: feiqi@medmail.com.cn
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reproduction in any medium, provided the orworld’s hip fractures, which contribute to the greatest
amount of morbidity and mortality, will occur in Asian
countries by the end of 2050 [2]. Once a person has devel-
oped osteoporosis or sustained fractures, restoration of
full bone strength is unlikely because of irreversible struc-
tural loss in bone microarchitecture [3-5]. It is therefore
very important to identify elderly populations at risk of de-
veloping osteoporosis and prevent the occurrence of the
first fracture.
There is an important need in China for osteoporosis
detection methodology. Measurement of bone mineral
density (BMD) using dual X-ray absorptiometry (DXA)
is widely accepted as the gold standard of osteoporosisd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Inclusion and exclusion criteria for this study
Inclusion criteria Exclusion criteria
Postmenopausal for
≥12 months
A history or evidence of metabolic bone




Han Chinese nationality Evidence of rheumatoid arthritis
Residency in Beijing
for ≥20 years
History of organ transplantation
Willingness to
participate in the study
The presence of cancer(s) with known
metastasis to bone
Ability to read informed
consent form




Evidence of significant renal impairment
Menopause before the age of 40 years
Previous fracture or replacement of both hips
The presence of a prolonged immobility
condition (e.g., spinal cord injury, Parkinson’s
disease, stroke, muscular dystrophy,
ankylosing spondylitis)
Prior use of an antiresorptive (e.g.
bisphosphonate, estrogen, selective estrogen
receptor modulators and calcitonin) or anabolic
agent (e.g. fluoride and parathormone-PTH)
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tures. Unfortunately, DXA is not widely available in
most developing countries including China because the
DXA and BMD measurement equipment are expensive.
There are currently several machines in some large
third-tier general hospitals in Beijing, but there are no
DXA machines in many cities in China. Hence, an
ideal simple screening tool to identify the elderly
population at risk for osteoporosis would not require
DXA measurements.
Advanced age and low body weight are strongly asso-
ciated with low BMD and with increased fracture risk
[6-9]. The Osteoporosis Self-Assessment Tools for
Asians (OSTA), which is based on age and body weight,
has been found to be a good and simple tool with high
sensitivity and acceptable specificity for the identification
of women at risk of osteoporosis in previous studies
[9-13]. However, another study reported poor results
when validating use of the OSTA for identifying post-
menopausal osteoporosis with lumbar spine DXA BMD
measurements in a Chinese cohort [14]. The use of
OSTA should be validated across diverse populations.
Because symptomatic osteoporotic vertebral fractures
are associated with significant morbidity, mortality, and
health and social service expenditures, it is important
that vertebral fractures are detected early, and that the
most appropriate treatments are administered as soon as
possible. Percutaneous kyphoplasty (PKP) is a widely ac-
cepted, effective means of treating recently acquired
painful osteoporotic vertebral fractures (new bone mar-
row edema on sagittal T1-weighted and fat-suppressed
T2-weighted images in magnetic resonance imaging
[MRI]), which can relieve pain quickly, increase stability
immediately, and recover vertebral body height. Osteo-
porosis, with or without painless fractures, can treated
effectively by pharmacological interventions. However,
relatively few patients with painful vertebral fractures
seek medical attention. Firstly, these patients often have
no trauma history and they may not know that their
acute back pain is associated with osteoporotic fracture.
Moreover, many physicians without experience in a pri-
mary hospital or community healthy service center may
also miss the diagnosis. Secondly, DXA and MRI are not
widely available in most developing countries, including
China. X-ray images do not reveal developmental varia-
tions in vertebral height (vertebral wedging and com-
pression) and cannot be used to judge fracture age. As a
result, patients with recently acquired painful vertebral
fractures may not be diagnosed correctly and may not
receive timely treatment. A good screening tool may be
helpful for patients as well as for physicians with limited
professional experience as an aide for identifying when
additional attention is needed and for selecting the most
appropriate therapy.It remains to be confirmed whether OSTA could be
used to identify recently acquired painful osteoporotic
vertebral fractures. Therefore, the objective of this study
was to validate the effectiveness of OSTA as an assess-
ment tool for identifying postmenopausal women at in-
creased risk of primary osteoporosis and recent painful
osteoporotic vertebral fractures in a large selected Han
Chinese population in Beijing.Methods
Study population
The study population included postmenopausal Chinese
women recruited from the osteoporosis clinic at the
Beijing Friendship Hospital from September 2010 to
October 2011. The study population included healthy
women who came to the hospital for health examina-
tions, and clinically symptomatic patients with a painful
vertebral fracture within the past 6 months who came
for further treatment. The inclusion and exclusion cri-
teria are listed in Table 1. Subjects with abnormal bio-
chemistry, including tests for renal and liver function,
serum calcium, phosphate, total alkaline phosphatase,
and thyroid-stimulating hormone, were also excluded.
The study was approved by the Ethics Committee of
Beijing Friendship Hospital, Capital Medical University
and all subjects had signed the informed consent.
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osteoporotic vertebral fractures
All women were invited to the osteoporosis clinic at
Beijing Friendship Hospital for DXA BMD measure-
ments of the hip and spine. The subjects were asked to
fill in a questionnaire by a trained interviewer to provide
demographic information and clinical risk factors for
osteoporosis by referring to a structured table [15], includ-
ing previous fragility fracture history, parental history of
hip fracture, glucocorticoid treatment history (>5 mg
prednisolone daily for 3 months or more), smoking, alco-
hol consumption, rheumatoid arthritis history, other sec-
ondary causes of osteoporosis mentioned in the exclusion
criteria and medical treatment history. Height was mea-
sured with a stadiometer. Weight was measured without
shoes in light indoor clothing using an electronic balance
scale (accuracy, 0.1 kg).
The BMD, expressed in g/cm2, was measured with the
use of the Hologic Discovery QDR Wi dencitometer
(Hologic, Inc., MA, USA) on the lumbar spine (L1–L4)
and left femur (femoral neck, trochanter, Ward’s triangle,
and total hip). The in vivo short-term reproducibility
values for the machine for postmenopausal women at the
lumbar spine, femoral neck and total hip were all lower
than 1%. The mean values from young Chinese women
were used to calculate the T-scores: L1–L4 BMD 0.967 ±
0.11 g/cm2, femoral neck 0.803 ± 0.10 g/cm2, and total hip
BMD 0.864 ± 0.11 g/cm2. All DXA measurements were
performed by an experienced technologist.
Excluding healthy women who came for routine screen-
ing, all clinically symptomatic patients accepted further
radiological examinations and treatments. We defined
four requisite clinical criteria to confidently identify new
painful osteoporotic vertebral fractures. These criteria
were as follows: (1) postmenopausal status without trauma
history or with a low-energy trauma history (low-energy
trauma fracture was defined as a fracture resulting
from a fall from a standing position or lower); (2) pain
occurring within 6 months prior to BMD measure-
ment; (3) acute or sub-acute vertebral fractures with
correlating clinical signs and signs demonstrated by X-
ray (i.e., height loss in the anterior, middle, or posterior
dimension of a vertebral body that exceeds 20% of the
vertebral body’s area in a lateral-view image of the
thoracic/lumbar spine; or the presence of endplate de-
formities, a lack of parallelism of the endplates and a
generally altered appearance relative to neighboring
vertebrae) and spine MRI imaging (new bone marrow
edema apparent in sagittal T1-weighted and fat-
suppressed T2-weighted images); and (4) no history or
evidence of metabolic bone disease or cancer. Patients
with an atypical MRI manifestation were subjected to
additional bone scanning. In this study, fractures were
confirmed according to the above clinical criteria.OSTA
The OSTA [10] was calculated based on age and body
weight using the following formula: [body weight (kg) − age
(year)] × 0.2.
The decimal digits were then disregarded. As de-
scribed in the original report [10], subjects with OSTA
values ≤ −1 were classified as having an increased risk of
osteoporosis and those with index values > −1 were con-
sidered to have a low risk for osteoporosis. For example,
a 77-year-old woman whose body weight was 45 kg
would have an OSTA index as calculated below: (45–77) ×
0.2 = −6.4. The decimal digit (0.4) was then disregarded,
and the OSTA index was equal to the integer −6. There-
fore, this subject was classified as having an increased risk
of osteoporosis.
Statistical analysis
Osteoporosis is defined arbitrarily when any T-score
(lumbar spine, femoral neck, or total hip) is −2.5 stand-
ard deviations (SD) or less, according to the World
Health Organization (WHO) criteria. In this study, the
characteristics of the OSTA risk index were examined at
a T-score cutoff of −2.5 (osteoporosis), and the T-scores
at individual BMD sites were used as outcome variables.
The ability of OSTA to discriminate low BMD as defined
by a T-score ≤ −2.5 was evaluated using receiver-
operating characteristic (ROC) curve analysis, which
plots sensitivity against (1–specificity). The area under
the curve (AUC), calculated using logistic regression,
was used to compare the diagnostic performance of the
two tests; AUC values > 0.75 are generally considered to
represent good performance. The pre-planned analysis
was based on femoral neck BMD as in the original
OSTA report, but results for lumbar spine BMD or total
hip BMD are also presented. Sensitivity was defined as
the proportion of women with osteoporosis (T-scores ≤ −2.5)
that tested positive (OSTA ≤ −1), and specificity was de-
fined as the proportion of women without osteoporosis
who tested normal (OSTA > −1). The ROC curve was
constructed, and the AUC and its 95% confidence inter-
val (95% CI) were estimated by using SPSS statistical
software 13.0 (SPSS, Inc.) and MedCalc v11.5.0.0 soft-
ware. The prevalence of osteoporosis defined by DXA
measurements according to the WHO criteria and the
prevalence of painful new vertebral fractures were ex-
amined across different categories of the OSTA risk
index. A p value less than 0.05 was considered statisti-
cally significant.
Results
A sample of 1320 postmenopausal women in Beijing
participated in this study. In accordance with the exclu-
sion criteria, 119 subjects were excluded from the study,
Table 2 Summary of descriptive characteristics of the
study cohort (n = 1201)
Characteristic Mean or value Range
Age (years, mean ± SD) 62.42 ± 9.27 45-89
Age group—n (%)
<50 years 52 (4.33%)
50–59 years 505 (42.05%) 50-59
60–69 years 330 (27.48%) 60-69
70–79 years 261(21.73%) 70-79
≥80 years 53 (4.41%) 80-89
Height (cm, mean ± SD) 158.64 ± 5.15 140-178
Weight (kg, mean ± SD) 60.47 ± 9.49 35-106
Body mass index (kg/m2, mean ± SD) 24.01 ± 3.50 14.34-39.41
BMD (g/cm2) (mean ± SD)
L1–L4 0.83 ± 0.15 0.370-1.534
Femoral neck 0.67 ± 0.13 0.269-1.160
Total hip 0.77 ± 0.14 0.268-1.235
T-score (mean ± SD)
L1–L4 T-score −1.29 ± 1.44 -5.2–5.3
Femoral neck T-score −1.34 ± 1.34 -5.5–3.6
Total hip T-score −0.83 ± 1.27 -5.5–3.4






Femoral neck 216/1201 (17.99)
Total hip 108/1201 (8.99)
History of fragility fracture—n (%) 341/1201(28.39)
OSTA score (mean ± SD) -0.35 ± 2.52 -10–8
aLowest BMD T-score in the lumbar spine, femoral neck, or total hip
was considered.
Figure 1 Distribution of study patients according to their OSTA
risk index.
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subjects included 173 women who had suffered a painful
vertebral fracture within 6 months before the BMD
measurement and 1028 healthy subjects attending for
routine screening without specific osteoporosis-associated
symptoms.
The characteristics of the study population are sum-
marized in Table 2. The average age of the women in
the study was 62 years old (range: 45–89 years). Overall,
the proportions of subjects found to have osteoporosis
based on femoral neck BMD T-scores ≤ −2.5, total
hip BMD T-scores ≤ −2.5, lumbar spine (L1–4) BMD
T-scores ≤ −2.5 were 17.99%, 8.99%, and 20.57%, re-
spectively. The mean body weight and mean body mass
index (BMI) were 60 kg and 24 kg/m2, respectively.
Based on the WHO criteria, the prevalence of osteoporosis
(femoral neck, total hip, or spine BMD T-score ≤ −2.5)
was 3.85% for ages 45–49 years (2 of 52), 13.86% for ages
50–59 (70 of 505), 30.91% for ages 60–69 (102 of 330),
55.17% for ages 70–79 (144 of 261), and 64.15% for ages ≥80
(34 of 53).
We then excluded the 173 women who had suffered a
painful vertebral fracture within the 6 months preceding
BMD measurement. Among the remaining 1028 subjects
who attended for routine screenings without specific
osteoporosis-associated symptoms, 229 (22.28%) had
osteoporosis. The prevalence of osteoporosis was 3.85%
(2/52) for patients in the 45–49 year-old age band,
13.05% (65/498) for patients in the 50–59 year-old age
band, 26.39% (76/288) for patients in the 60–69 year-old
age band, 44.97% (76/169) for patients in the 70–79 year-
old age band, and 47.62% (10/21) for patients in the ≥ 80
year-old age band. Thus, the prevalence of osteoporosis
increased progressively with age (χ2trend = 9.63, P <0.001).
The OSTA index varied from −10 to 8, and the percent
distribution of the women according to the OSTA index is
shown in Figure 1. Based on the osteoporosis risk categor-
ies used in Asian women [10], 59.45% of the women
(n = 714, OSTA > −1) had a low risk, and 40.55% (n = 487,
OSTA ≤ −1) of the women had an increased risk of osteo-
porosis. Approximately 28.39% (n = 341) of the studied
women reported a history of low-trauma fracture (≥ 45 years,
including those of the spine, hip, distal forearm, proximal
humerus, and malleolus). Furthermore, among the 341
women with previous fragility fractures, 173 had suffered
a painful vertebral fracture within 6 months before the
BMD measurement, and 164 of these 173 women were
confirmed to have recent painful osteoporotic vertebral
fractures according to the clinical criteria mentioned
above. Most women with painful vertebral fractures were
admitted to Beijing Friendship Hospital and consented to
PKP and osteoporosis treatments, including subcutaneous
or intranasal rectal calcitonin and calcium and vitamin D
supplementation. The remaining women who did not
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itional management including analgesia, rest with a cor-
set support, and subsequent gradual mobilization within
the limits of pain. Significant differences in age, BMI,
BMD, T-scores, and OSTA variables were observed be-
tween the group of postmenopausal women with verte-
bral fractures and the group with no vertebral fractures
(P < 0.01).Figure 2 Distribution of T-scores by OSTA index value. TheCorrelation between OSTA index values and BMD
T-scores in postmenopausal women
There was a moderate positive correlation between
OSTA index values and BMD T-scores at different sites
(femoral neck: r = 0.580, P < 0.001; total hip: r = 0.589,
P < 0.001; L1–4: r = 0.489, P < 0.001). Figure 2 shows
the distribution of T-scores at the femoral neck, total
hip, and L1–L4 lumbar spine by the OSTA index values.
The area under the ROC curve for the OSTA index for
the femoral neck, total hip, and L1–4 lumbar spine were
0.824 (P < 0.001), 0.824 (P < 0.001), and 0.776 (P < 0.001),
respectively (Figure 3). Furthermore, the index cutoff
of −1 provided a sensitivity of 74–83% and a specificity of
63–68%, whereas the sensitivity and specificity for an
index cutoff of −4 were 32–52% and 93–95%, respectively
(Figure 3). The optimal OSTA index cutoff at the femoral
neck, total hip, and L1–4 lumbar spine were −1, -3, and −1,
respectively (Figure 3).
As reported in detail in Table 3, we found that among
the 1028 subjects who attended for routine screenings,
the presence of osteoporosis was found in 44% and 11%
of subjects in the increased risk group and low-risk
group, respectively, when using BMD measurements at
either the femoral neck or lumbar spine to diagnose
osteoporosis. The sensitivity, specificity, positive pre-
dictive value (PPV) and negative predictive value
(NPV) of the OSTA index for detecting osteoporosis
were calculated for the overall population and by age
groups. Among these women who attended for routine
screenings, the sensitivity was 65.9% (151/229; 95% CI,
59.4-72.1), the specificity 75.5% (603/799; 95% CI, 72.3-
78.4), PPV 43.5% (151/347; 95% CI, 38.2-48.9), and the
NPV 88.5 (603/681; 95% CI, 85.9-90.8). The data ana-
lyzed by age groups showed that sensitivity and PPV
increased with age, while specificity and NPV decreased
with age.horizontal line demarcates a T-score of -2.5 and the vertical lines
mark the OSTA risk index cutoffs of -1 and -4.OSTA and the prevalence of vertebral fracture in
postmenopausal women
With regard to new painful osteoporotic vertebral frac-
tures, the area under the ROC curve (Figure 4) relating
the OSTA index to identify vertebral fracture was 0.812
(95% CI: 0.789 to 0.834, Z = 18.592, P < 0.001). The op-
timal OSTA cutoff was −1.Discussion
Simple noninvasive diagnostic tools, such the OSTA, for
detecting osteoporosis and predicting fracture risks in
postmenopausal women are very important, particularly
in places, such as China, where DXA technology is not
Figure 3 AUC and sensitivity and specificity values of the OSTA index for the diagnosis of osteoporosis (T-score ≤ −2.5 SD) using BMD
measurements at the femoral neck (a), total hip (b), and L1–L4 vertebrae (c).
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found to have high sensitivity and good specificity for
identifying primary osteoporosis in postmenopausal Han
Chinese women in Beijing. More importantly, we found
that this tool may be useful for identifying new clinical
vertebral fractures.
Compared to the majority of previous studies, this
study had several noteworthy strengths. Firstly, our
study was not retrospective. Both healthy women who
came to the hospital for health examinations and clinical
patients were selected for this study according to strictTable 3 Distribution of clinical index based on femoral neck (
screening group
Group OSTA value FN, TH, or L1–4 BMD Tot
T ≤ −2.5 T > −2.5
Routinely screened, all ages High risk (≤ −1) 151 196 34
Low risk (> −1) 78 603 68
Total 229 799 102
< 60 years High risk (≤ −1) 20 43 63
Low risk (> −1) 47 44 48
Total 67 483 55
60–69 years High risk (≤ −1) 52 75 12
Low risk (> −1) 24 137 16
Total 76 212 28
≥ 70 years High risk (≤ −1) 79 78 15
Low risk (> −1) 7 26 33
Total 86 104 19
PPV positive predictive value, NPV negative predictive value.clinical criteria. All of the subjects’ weights and heights
were measured at the same time as that BMD measure-
ments were taken. Secondly, we built strict inclusion
and exclusion criteria to exclude the effects of secondary
osteoporosis, nationality, and any antiresorptives/ana-
bolic agents. All women were Beijing citizens with long-
term residency in Beijing. Thirdly, most previous studies
defined osteoporosis by a T-score ≤ −2.5 only at the fem-
oral neck. In this study, we analyzed the value of OSTA
for identifying osteoporosis based on the WHO criteria
(T-score ≤ −2.5 at the femoral neck, total hip, or lumbarFN), total hip (TH), or lumbar spine BMDs in routine
al Sensitivity Specificity PPV NPV
% 95% CI % 95% CI % 95% CI % 95% CI
7 65.9 59.4–72.1 75.5 72.3–78.4 43.5 38.2–48.9 88.5 85.9–90.8
1
8
29.9 19.3–42.3 91.1 88.2–93.5 31.7 20.6–44.7 90.3 87.4–92.8
7
0
7 68.4 56.7–78.6 64.6 57.8–71.0 69.3 57.6–79.5 85.1 78.6–90.2
1
8
7 91.9 83.9–96.7 25.0 17.0–34.4 50.3 42.2–58.4 78.8 61.1–91.0
0
Figure 4 Relation of OSTA to the prevalence of new vertebral fracture in the increased risk group and low risk group according to the
OSTA classification scheme. (a) Prevalence of new vertebral fracture by groups. (b) ROC curve.
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accepted that osteoporosis patients diagnosed according
to the WHO criteria should receive specific bone active
treatments, such as antiresorptive or anabolic agents.
Furthermore, for the first time, we evaluated the value of
OSTA for identifying recently acquired symptomatic clin-
ical vertebral fractures, which were confirmed by reason-
able clinical criteria. As one of the largest general hospitals
in Beijing, our patient population had a wide representa-
tion in terms of age, height, weight, and BMD status.
This study was the first to analyze the correlation be-
tween the OSTA index and BMD T-scores at different
sites. The results indicated a significant positive correl-
ation. Furthermore, we started to validate the usefulness
of the OSTA in the studied cohort. An index cutoff
of −1 provided high sensitivity (74–83%) and good speci-
ficity (63–68%) for identifying subjects with a BMD
T-score ≤ −2.5 at different skeletal sites relative to previ-
ously reported data [9-13]. The optimal OSTA cutoff
may vary with different skeletal sites. The AUC for
OSTA was approximately 0.8 at the different skeletal
sites. The results were similar to a previous study in a
southern Chinese cohort [11] in which 259 of 487
women with an OSTA index ≤ −1 (increased risk group)
and only 93 of 714 women with OSTA index > −1 (low risk
group) were diagnosed with osteoporosis in accordance
with the WHO criteria. Among 1028 women aged 45 years
or older who came for routine screening, using a cutoff of
OSTA≤ −1, we obtained sensitivity of 65.9%, specificity of
75.5%, a PPV of 43.5%, and an NPV of 88.5. Although the
PPV was only 43.5%, more importance should be given to
specificity than sensitivity. A high specificity and a low
positivity rate of OSTA index can be translated into a low
referral rate for BMD measurement by DXA. With these
rates, only high-risk women (OSTA≤ −1) would bereferred to physicians because of OSTA’s high specifi-
city, especially among postmenopausal women younger
than 60 years of age, yielding a specificity greater than
90%. Referring only high-risk women could potentially
enhance resource use efficiency. BMD measurements in
low-risk women can be avoided and proper medical care
in high-risk women encouraged. Moreover, there is no
risk of harm to the patient from unnecessary treatment
or invasive diagnostic testing in the case of a false-positive
result from the OSTA.
Several studies show that OSTA is an effective method
for identifying people at low risk of osteoporosis [12,13].
Our data showed that the OSTA could identify women
at low risk of osteoporosis for whom DXA testing was
unnecessary. The NPV was 88.5% in the overall popula-
tion and 90.3% in postmenopausal women under 60 years
of age. PPV of OSTA increased with age, while NPV de-
creased with age. However, NPV was only 78.8% among
women ≥ 70 years. Therefore, we can recommend that
high risk women younger 70 years of age be referred for
BMD measurement, while all women 70 years old or older
be referred for BMD measurement due to the high preva-
lence of osteoporosis and poor NPV among women in this
age group.
It is widely accepted that postmenopausal women with
fragility fractures have a high risk of subsequent fractures,
and are therefore eligible for treatment to reduce the risk
of future fractures [16-18]. Previous studies showed that
the OSTA may be a simple and effective tool for identifying
postmenopausal women at increased risk of nonvertebral
fractures and vertebral deformity [5,19]. However, it was
not clear whether the OSTA index could identify painful
new vertebral fractures. In our study population, we
assessed the ability of OSTA to identify postmenopausal
women with painful new vertebral fractures. All 164
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able clinical criteria, and most of the patients accepted
PKP treatment. Sensitivity and specificity values of 82%
and 67%, respectively, were obtained with an OSTA cut-off
value ≤ −1. The area under the ROC curve relating the
OSTA index to new vertebral fractures was 0.70. The
prevalence of vertebral deformities according to the OSTA
index was 27.5% (134/487) in the increased risk group, and
4.2% (30/714) in the low risk group. Our findings showed
the OSTA index may be a useful tool to screen for new
painful vertebral fractures.
The present study has several limitations. First, the
subjects who were recruited from an osteoporosis center
in a general hospital could not fully represent the actual
female population in Beijing. According to population
census in 2011, the women in the 50–59-year-old, 60–
69-year-old, 70–79-year-old, and ≥ 80 year-old age bands
accounted for 61%, 23%, 13%, and 4% of the total
women aged 50 years or older, respectively. The popula-
tion structure of our study was different from the actual
demographic situation in Beijing, which could impact
the generalizability of these data. However, the clinical
performance of OSTA was analyzed by age group, and
our conclusions were based on this analysis. Secondly,
we could not assess the value of OSTA for identifying
painful nonvertebral fractures in this study. Thirdly, our
results should be confirmed in other cohorts.
Conclusion
In summary, the present study showed that in postmen-
opausal Han Chinese women in Beijing, the OSTA index
may be a simple and effective clinical risk assessment
tool for identifying the risk of osteoporosis as defined by
DXA according to the WHO diagnostic criteria, and it
may be a useful tool for identifying new painful vertebral
fractures. Given the simplicity and validity of the OSTA
index and the benefits shown in our study, we can rec-
ommend it as an important health-promotion activity to
women, especially postmenopausal women under 70
years of age.
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